Eli Lilly and Company News Releases

Lilly's P-tau217 Blood Test Shows High Accuracy in Diagnosis of Alzheimer's Disease in Data Published in JAMA

New Alzheimer's disease blood test could enable early diagnosis and advance understanding of how disease impacts those living with it INDIANAPOLIS , July 28, 2020 /PRNewswire/ -- A new study on Lilly 's blood test for Alzheimer's disease (AD), P-tau217 (phosphorylated tau at threonine-217), was
favicon
investor.lilly.com
investor.lilly.com
Create attached notes ...